Tadepally Lakshmikanth

Author PubWeight™ 13.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle 2011 2.43
2 The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2008 2.24
3 Mechanical stress downregulates MHC class I expression on human cancer cell membrane. PLoS One 2014 1.41
4 Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets. J Immunol 2012 1.11
5 In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2. Eur J Immunol 2010 1.01
6 Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS One 2010 0.96
7 New views on natural killer cell-based immunotherapy for melanoma treatment. Trends Immunol 2010 0.91
8 Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells. J Immunol 2009 0.86
9 Distinct and overlapping patterns of cytokine regulation of thymic and bone marrow-derived NK cell development. J Immunol 2009 0.86
10 Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level. J Biomed Opt 2010 0.81
11 A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia 2014 0.78
12 A novel facet of tumor suppression by p53: Induction of tumor immunogenicity. Oncoimmunology 2012 0.77